Business
AstraZeneca moves to start making a profit from its vaccine – Sydney Morning Herald
After looking on as Pfizer and Moderna have made billions of dollars in sales, AstraZeneca is shifting to a for-profit model.
The vaccine isnt yet authorised in the US, after the company missed the window for an emergency authorisation due to the complicated nature of its trial results. Astra is planning to submit the shot for approval to regulators in the first half of next year,…
Continue Reading
-
Business23 hours agoWhat it means for shareholders
-
Noosa News23 hours agoCalls for greater education as growers in WA’s south-west brace for polyphagous shot-hole borer
-
General22 hours agoKim Kardashian not deterred by bar failure
-
Business17 hours agoMacquarie tips more than 20% upside for this ASX mining stock